Our panel at the BIO International Convention in 2016 brought together senior leaders from industry, government and health care organisations to discuss the strengths of the clinical trials environment and recently introduced operational efficiencies. The audience, which consisted of representatives from pharmaceutical companies, biotechnology firms, government agencies and Canada’s trade commissions, provided feedback on how Canada can further improve its competitiveness as a destination for clinical trials.

Panel presentation materials are available here.